Literature DB >> 18818321

Points of recombination in Epstein-Barr virus (EBV) strain P3HR-1-derived heterogeneous DNA as indexes to EBV DNA recombinogenic events in vivo.

Kazufumi Ikuta1, Shamala K Srinivas, Tim Schacker, Jun-ichi Miyagi, Rona S Scott, John W Sixbey.   

Abstract

Deletions and rearrangements in the genome of Epstein-Barr virus (EBV) strain P3HR-1 generate subgenomic infectious particles that, unlike defective interfering particles in other viral systems, enhance rather than restrict EBV replication in vitro. Reports of comparable heterogeneous (het) DNA in EBV-linked human diseases, based on detection of an abnormal juxtaposition of EBV DNA fragments BamHI W and BamHI Z that disrupts viral latency, prompted us to determine at the nucleotide level all remaining recombination joints formed by the four constituent segments of P3HR-1-derived het DNA. Guided by endonuclease restriction maps, we chose PCR primer pairs that approximated and framed junctions creating the unique BamHI M/B1 and E/S fusion fragments. Sequencing of PCR products revealed points of recombination that lacked regions of extensive homology between constituent fragments. Identical recombination junctions were detected by PCR in EBV-positive salivary samples from human immunodeficiency virus-infected donors, although the W/Z rearrangement that induces EBV reactivation was frequently found in the absence of the other two. In vitro infection of lymphoid cells similarly indicated that not all three het DNA rearrangements need to reside on a composite molecule. These results connote a precision in the recombination process that dictates both composition and regulation of gene segments altered by genomic rearrangement. Moreover, the apparent frequency of het DNA at sites of EBV replication in vivo is consistent with a likely contribution to the pathogenesis of EBV reactivation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818321      PMCID: PMC2583645          DOI: 10.1128/JVI.01036-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region.

Authors:  B D Parker; A Bankier; S Satchwell; B Barrell; P J Farrell
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

2.  Polymorphisms of the region of the Epstein-Barr virus genome which disrupts latency.

Authors:  H B Jenson; G Miller
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

3.  Epstein-Barr virus with heterogeneous DNA disrupts latency.

Authors:  G Miller; M Rabson; L Heston
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

4.  Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia.

Authors:  K Gilligan; P Rajadurai; L Resnick; N Raab-Traub
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

5.  Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.

Authors:  N Mueller; A Evans; N L Harris; G W Comstock; E Jellum; K Magnus; N Orentreich; B F Polk; J Vogelman
Journal:  N Engl J Med       Date:  1989-03-16       Impact factor: 91.245

6.  Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia.

Authors:  D F Patton; P Shirley; N Raab-Traub; L Resnick; J W Sixbey
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

7.  Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats.

Authors:  C M Nuebling; N Mueller-Lantzsch
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Early events in Epstein-Barr virus infection of human B lymphocytes.

Authors:  C Alfieri; M Birkenbach; E Kieff
Journal:  Virology       Date:  1991-04       Impact factor: 3.616

9.  Epstein-Barr virus antibody patterns preceding the diagnosis of non-Hodgkin's lymphoma.

Authors:  N Mueller; A Mohar; A Evans; N L Harris; G W Comstock; E Jellum; K Magnus; N Orentreich; B F Polk; J Vogelman
Journal:  Int J Cancer       Date:  1991-09-30       Impact factor: 7.396

10.  A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection.

Authors:  J W Sixbey; P Shirley; M Sloas; N Raab-Traub; V Israele
Journal:  J Infect Dis       Date:  1991-05       Impact factor: 5.226

View more
  1 in total

1.  Epithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.

Authors:  Kazufumi Ikuta; Mingyu Ding; Fangfang Zhang; John W Sixbey; Rona S Scott
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.